文献速递神经肿瘤

间变性胶质瘤患者的免疫相关长链非编码RNA特征

An immune-related lncRNA signature for patients with anaplastic gliomas.
PubMed 文献 · J Neurooncol · 2017-11-23

研究从中国胶质瘤基因组图谱芯片中获取572个长链非编码RNA和317个免疫基因,构建免疫相关长链非编码RNA共表达网络,在间变性胶质瘤患者中识别出由9个免疫相关长链非编码RNA组成的特征。低风险组较高风险组总生存期和无进展生存期更长(P < 0.0001;P < 0.0001),该特征为独立预后因素(P = 0.000,HR = 1.434),并在GSE16011和REMBRANDT两个数据集中验证。

要点

  • 识别出9个免疫相关长链非编码RNA特征,对间变性胶质瘤具有预后价值。
  • 低风险组总生存期和无进展生存期均较高风险组更长(P < 0.0001;P < 0.0001)。
  • 该特征为独立预后因素,与总生存期显著相关(P = 0.000,HR = 1.434)。

核心结论

  • 九种免疫相关长链非编码RNA特征对间变性胶质瘤具有预后价值。

研究设计与样本

  • 从中国胶质瘤基因组图谱芯片获取572个长链非编码RNA和317个免疫基因,构建免疫相关长链非编码RNA共表达网络以识别免疫相关长链非编码RNA。
  • 使用另外两个数据集(GSE16011、REMBRANDT)进行验证。
  • 采用基因集富集分析和主成分分析进行功能注释。

主要发现

  • 在间变性胶质瘤患者中识别出由SNHG8、PGM5-AS1、ST20-AS1、LINC00937、AGAP2-AS1、MIR155HG、TUG1、MAPKAPK5-AS1和HCG18组成的九种免疫相关长链非编码RNA特征。
  • 低风险组患者总生存期和无进展生存期均较高风险组更长(P < 0.0001;P < 0.0001)。
  • 高风险组患者显示染色体臂1p和/或19q无缺失、异柠檬酸脱氢酶野生型、经典和间充质TCGA亚型、G3 CGGA亚型以及较低的卡氏功能评分。
  • 该特征为独立因素,与总生存期显著相关(P = 0.000,风险比(HR)= 1.434)。
  • 上述发现在另外两个数据集(GSE16011、REMBRANDT)中得到进一步验证。

关键数值与推荐

  • 低风险组与高风险组总生存期比较P < 0.0001,无进展生存期比较P < 0.0001。
  • 该特征与总生存期相关:P = 0.000,HR = 1.434。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated immune-related long non-coding RNAs (lncRNAs) that may be exploited as potential therapeutic targets in anaplastic gliomas. We obtained 572 lncRNAs and 317 immune genes from the Chinese Glioma Genome Atlas microarray and constructed immune-related lncRNAs co-expression networks to identify immune-related lncRNAs. Two additional datasets (GSE16011, REMBRANDT) were used for validation. Gene set enrichment analysis and principal component analysis were used for functional annotation. Immune-lncRNAs co-expression networks were constructed. Nine immune-related lncRNAs (SNHG8, PGM5-AS1, ST20-AS1, LINC00937, AGAP2-AS1, MIR155HG, TUG1, MAPKAPK5-AS1, and HCG18) signature was identified in patients with anaplastic gliomas. Patients in the low-risk group showed longer overall survival (OS) and progression-free survival than those in the high-risk group (P < 0.0001; P < 0.0001). Additionally, patients in the high-risk group displayed no-deletion of chromosomal arms 1p and/or 19q, isocitrate dehydrogenase wild-type, classical and mesenchymal TCGA subtype, G3 CGGA subtype, and lower Karnofsky performance score (KPS). Moreover, the signature was an independent factor and was significantly associated with the OS (P = 0.000, hazard ratio (HR) = 1.434). These findings were further validated in two additional datasets (GSE16011, REMBRANDT). Low-risk and high-risk groups displayed different immune status based on principal components analysis. Our results showed that the nine immune-related lncRNAs signature has prognostic value for anaplastic gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wang W, Zhao Z, Yang F, et al. An immune-related lncRNA signature for patients with anaplastic gliomas. J Neurooncol. 2017. PMID: 29170907. doi:10.1007/s11060-017-2667-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。